All In MedTech

Company

Abbott

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

Abbott is on our public-company list (ticker ABT). Names searched as well: Abbott Vascular, Abbott Medical, Abbott Diabetes Care, St. Jude Medical. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.

Public

Listed

ABT

NYSE · ABBOTT LABORATORIES

Public float

$232.2B

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$44.3B

Fiscal year ending Dec 31, 2025

Net income

$6.52B

Fiscal year ending Dec 31, 2025

R&D spending

$2.94B

Fiscal year ending Dec 31, 2025

Cash

$4.05B

As of Sep 30, 2026

Long-term debt

$29.5B

As of Sep 30, 2026

Shares outstanding

1731.9M

As of Sep 30, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2021––$4.0M–

Private placements (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Mar 1, 2011Debt$100K$100K1Rule 506Agent: Goldman Sachs & Co.Commissions $200Form D ↗Mar 15, 2011
Mar 1, 2010Debt$70K$70K1Rule 506Agent: Goldman, Sachs & Co.Commissions $140Form D/A ↗Mar 12, 20101 amendment

Company details

From the company's latest Form D.

Legal name
ABBOTT LABORATORIES
Headquarters
Abbott Park, Illinois
Incorporated
Illinois over five years before filing
Entity type
Corporation
Revenue range
Over $100,000,000
Industry filed under
Pharmaceuticals
SEC filer
CIK 1800 ↗

Executives, directors and promoters

As listed on the latest Form D.

    31 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    The investor database is part of the paid tier

    For Abbott we have 1 shareholder with 5% or more.

    It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

    Latest FDA decisions

    The 8 newest of 282 since 2015.

    Search the Clearance Tracker

    279 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar
    • NCT04011722 · 333 participants · Start Sep 17, 2019 · Primary completion Jan 12, 2023

      Device: Portico™ NG (Navitor) Valve and FlexNav™ Delivery System; Navitor Titan Valve (35mm) Valve and Large FlexNav™ Delivery System · For: Symptomatic Severe Aortic Stenosis

      Sites: Los Angeles, California; Thousand Oaks, California; Washington D.C., District of Columbia · 28 sites in all

    • NCT06590467 · 2,500 participants (planned) · Start Aug 21, 2024 · Primary completion Dec 2029

      Device: Amplatzer™ Occlusion Devices; Epic™ Surgical Tissue Heart Valve devices · For: Heart Diseases; ASD - Atrial Septal Defect; VSD - Muscular Ventricular Septal Defect and 3 more

      Sites: Los Angeles, California; Washington D.C., District of Columbia; Miami, Florida · 36 sites in all

    • NCT07798726 · 565 participants (planned) · Start Oct 21, 2026 · Primary completion Dec 31, 2031

      Device: Cephea Mitral Valve System · For: Mitral Valve Disease; Mitral Annulus Calcification; Mitral Regurgitation and 6 more

      Sites: Wichita, Kansas

    547 more trials with a free account

    Reports received

    524,059

    Received Nov 1, 2025 to Nov 19, 2026. Includes 155 of another or unstated type.

    Malfunction reports

    474,836

    91% of reports

    Injury reports

    47,775

    9.1% of reports

    Death reports

    1,293

    0.2% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 234,5844,630610
    Jan 245,2025,040674
    Feb 244,6064,8701060
    Mar 244,4564,917672
    Apr 245,6015,140640
    May 245,3965,2151083
    Jun 244,7975,134620
    Jul 245,9445,143601
    Aug 246,5725,465801
    Sep 245,4225,042661
    Oct 245,6325,4611001
    Nov 245,0754,813882
    Dec 244,8205,169681
    Jan 255,0874,321800
    Feb 255,1164,258853
    Mar 255,5614,506900
    Apr 256,1654,6011111
    May 255,9164,391871
    Jun 256,1434,6301351
    Jul 257,1974,6081052
    Aug 256,2594,5521500
    Sep 256,0554,081740
    Oct 255,8854,1181212
    Nov 255,6643,3021181
    Dec 257,9214,1121250
    Jan 268,3653,4481275
    Feb 265,7373,5811141
    Mar 2610,4953,9841062
    Apr 2639,9464,3931122
    May 2644,4724,4061200
    Jun 2648,0274,4371230
    Jul 2635,0054,2928934
    Aug 26132,5943,9769885
    Sep 26117,5774,1168013
    Oct 2619,0333,7288112
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    7 more in this ranking with a free account

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    1,083 more recall records with a free account

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.